It was originally thought that patients with liver transplants could experience more severe consequences of a COVID-19 infection due to other comorbidities and patients' intake of immunosuppressants. The results of an international registry study show that patients with liver transplants did not have an increased risk of mortality, but rather those who are of old age, male sex, have high serum creatinine concentration, or existing diseases did tend to have a higher risk of COVID-19 related mortality.